Help your eligible patients reduce their out-of-pocket costs
100% of eligible commercially insured patients can get BREO
Restrictions apply. Subject to eligibility.
A coupon for eligible patients to pay no more than $10 for each prescription for up to 12 months of BREO (30-day supplies). Not for Medicare enrollees, participants in other government programs, or patients aged 65 years or older.
The brands listed, with the exception of BREO and ELLIPTA, are trademarks or registered trademarks of their respective owners and are not trademarks of the GSK group of companies. The makers of these brands are not affiliated with and do not endorse GSK or its products.
Offer is good for up to 12 uses. Patients in government programs, including Medicare, are not eligible for savings offers. Please see the savings offer for complete rules and eligibility.
Eligible commercially insured patients will pay $10 per 30-day supply of BREO. Eligible patients without insurance to cover the cost of their prescription will receive up to $100 in savings on each 30-day supply of BREO. Patients will be responsible for any remaining out-of-pocket cost. Please visit GSKforyou.com for more details.
More tools for your eligible patients
Patient Assistance for your eligible patients
GSKForYou is for patients who need help paying for their GSK prescription medications. See if your patients are eligible to receive their GSK medication at no cost to them.
- Bernstein DI, Bateman ED, Woodcock A, et al. Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma. J Asthma. 2018;55(8):890-897.
- Bleecker ER, Lötvall J, O’Byrne PM, et al. Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial. J Allergy Clin Immunol Pract. 2014;2(5):553-561.
- Bateman ED, O’Byrne PM, Busse WW, et al. Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone. Thorax. 2014;69(4):312-319.
- Data on file, GSK.
- O’Byrne PM, Bleecker ER, Bateman ED, et al. Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma. Eur Respir J. 2014;43:773-782.
- Kerwin E, Barnes N, Gibbs M, et al. Fluticasone furoate/vilanterol once daily improves night-time awakenings in asthma patients with night symptoms; post-hoc analyses of three randomized controlled trials. J Asthma. 2018;55(8):890-897.
- Data on file, GSK. Study 201594.